Market Closed -
Other stock markets
|
After market 01:12:06 pm | |||
59.5 EUR | +0.37% | 59.46 | -0.07% |
May. 02 | DANONE : UBS keeps its Buy rating | ZD |
May. 02 | Danone: acquisition of Functional Formularies | CF |
Sales 2024 * | 27.6B 29.76B | Sales 2025 * | 28.64B 30.87B | Capitalization | 38.05B 41.02B |
---|---|---|---|---|---|
Net income 2024 * | 2.19B 2.36B | Net income 2025 * | 2.36B 2.55B | EV / Sales 2024 * | 1.71 x |
Net Debt 2024 * | 9.11B 9.82B | Net Debt 2025 * | 8.27B 8.92B | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 * |
17.3
x | P/E ratio 2025 * |
16.1
x | Employees | 88,843 |
Yield 2024 * |
3.61% | Yield 2025 * |
3.81% | Free-Float | 93.12% |
Latest transcript on Danone
1 day | +0.20% | ||
1 week | +2.87% | ||
Current month | +1.26% | ||
1 month | +3.27% | ||
3 months | -2.64% | ||
6 months | +3.54% | ||
Current year | +1.23% |
Managers | Title | Age | Since |
---|---|---|---|
Shane Grant
CEO | Chief Executive Officer | - | 21-03-14 |
Chief Executive Officer | 58 | 21-09-14 | |
Juergen Esser
DFI | Director of Finance/CFO | 53 | 99-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lise Kingo
BRD | Director/Board Member | 62 | 22-11-30 |
Gilles Schnepp
CHM | Chairman | 64 | 20-12-13 |
Géraldine Picaud
BRD | Director/Board Member | 54 | 22-04-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.97% | 5 M€ | +4.56% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 59.5 | +0.37% | 1 127 441 |
24-05-09 | 59.28 | -0.07% | 756,721 |
24-05-08 | 59.32 | +1.02% | 1,085,047 |
24-05-07 | 58.72 | +1.07% | 1,012,483 |
24-05-06 | 58.1 | +0.62% | 816,925 |
Real-time Euronext Paris, May 10, 2024 at 03:16 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.23% | 41B | |
-3.37% | 272B | |
-3.08% | 94.16B | |
-3.43% | 43.36B | |
+7.32% | 40.46B | |
+7.86% | 39.67B | |
-13.54% | 30.87B | |
-5.05% | 29.02B | |
+14.07% | 25.11B | |
-4.01% | 24.06B |
- Stock Market
- Equities
- BN Stock